Higher mortality during heatwave in July in the Netherlands During the last heatwave, almost 400 more deaths were reported than was expected on overage for that period. The additional deaths mainly concerned persons aged 75 years and older.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.
National Action Plan for sexual health The Dutch National Action Plan for STI, HIV and sexual health describes the most important goals for the next five years.
Greenhouse gas emissions slightly down in 2017 Despite the growth of the economy, greenhouse gas emissions in the Netherlands in 2017 were1 percent lower than in the previous year.
Addictive nicotine and harmful substances also present in heated tobacco Heated tobacco products are newly available on the market. An example of such a product is the heatstick which is heated with an iQOS, a device that looks like an e-cigarette.
Continued high effectiveness of vaccines against Hib disease A recent study by RIVM and AMC shows that the effectiveness of vaccination against Hib is still high.